Latest Headlines
-
Nanoform Starts Pivotal Human Bioequivalence Studies Of Nanoenzalutamide
6/12/2025
Nanoform Finland Plc, the medicine performance-enhancing company, today announced that it had started pivotal relative bioequivalence studies of Nanoenzalutamide, the nanocrystalline-enabled enzalutamide tablet formulation, a potential alternative to the amorphous solid dispersion (ASD) used in XTANDI® (enzalutamide) [1], the number one prescribed androgen receptor inhibitor [2] approved to treat prostate cancer.
-
Parker To help Biopharmaceutical Manufacturers Transform Tangential Flow Filtration
6/12/2025
Optimizing, streamlining and scaling tangential flow filtration processing in the biopharmaceutical industry will be the focus of a Parker webinar this month.
-
Nelson Labs Increasing Cleanroom Capacity To Support Increasing Demand For Sterility Assurance Services
6/12/2025
Nelson Laboratories, a global leader in microbiological and analytical testing services for the medical device and pharmaceutical industries, today announced the groundbreaking of a major cleanroom expansion project at its global headquarters in Salt Lake City, Utah. The expansion will double the lab’s existing ISO-classified cleanroom capacity, supporting growing demand for sterility assurance testing and reinforcing Nelson Labs’ role as a trusted partner to pharmaceutical and medical device manufacturers navigating evolving global regulations.
- Simtra BioPharma Solutions And MilliporeSigma Announce Strategic Alliance For Antibody Drug Conjugates Drug Substance And Drug Product Manufacturing Services 6/12/2025
-
SCHOTT Pharma Invests In Sterile Cartridge Production In Hungary
6/5/2025
SCHOTT Pharma, a pioneer in drug containment and delivery solutions, is investing more than 100 million euros in its existing site in Lukácsháza, Hungary, to expand its capacity for sterile ready-to-use (RTU) cartridges.
-
CDMO Bora Pharmaceuticals Procures New Aseptic Filling And Closing System From AST
5/29/2025
AST, a leading provider of flexible drug product manufacturing solutions, has announced the placement of its advanced isolated GENiSYS C fill-finish system with Bora Pharmaceuticals, a premier international contract development and manufacturing organization (CDMO). The flexible, multi-format system will be placed in their 87,000-square-foot clinical-to-commercial drug product manufacturing facility in Baltimore, Maryland.
-
Mettler-Toledo Helps Manufacturers Cut Costs And Risk With Test Before You Invest Program
5/28/2025
With operational costs rising and production line efficiency under pressure, manufacturers need to be confident that any new equipment investment will deliver value. Mettler-Toledo Product Inspection’s Test Before You Invest program is designed to help food, pharmaceutical and packaging manufacturers make informed product inspection choices through hands-on testing, real performance data and expert support.
- CDMO Siegfried Announces Plans To Expand Manufacturing Capacity For Ophthalmic Drugs In Spain 5/28/2025
-
Cellular Origins And 3P innovation Collaborate To Accelerate Industrialisation Of CGT Manufacturing
5/21/2025
Cellular Origins, a TTP Company, focused on enabling scalable, cost-effective, and efficient manufacture of cell and gene therapies (CGTs), today announced a collaboration with 3P innovation, a leading engineering company and supplier of automated fill-finish equipment.
-
ACG Unveils Patented Personalized Capsule Technology
5/20/2025
ACG, a global provider of fully integrated manufacturing solutions for the pharmaceutical and nutraceutical industries, introduces its world-first Personalised Capsule Machine (PCM) – a patented technology that creates custom-formulated supplement capsules tailored to individual needs on demand. The PCM merges real-time health data, precision dosing, and automated capsule production to create individualised supplements.